SARS-CoV-2 Wastewater Genomic Surveillance: Approaches, Challenges, and Opportunities
Authors:
Viorel Munteanu,
Michael Saldana,
Dumitru Ciorba,
Viorel Bostan,
Justin Maine Su,
Nadiia Kasianchuk,
Nitesh Kumar Sharma,
Sergey Knyazev,
Victor Gordeev,
Eva Aßmann,
Andrei Lobiuc,
Mihai Covasa,
Keith A. Crandall,
Wenhao O. Ouyang,
Nicholas C. Wu,
Christopher Mason,
Braden T Tierney,
Alexander G Lucaci,
Alex Zelikovsky,
Fatemeh Mohebbi,
Pavel Skums,
Cynthia Gibas,
Jessica Schlueter,
Piotr Rzymski,
Helena Solo-Gabriele
, et al. (3 additional authors not shown)
Abstract:
During the SARS-CoV-2 pandemic, wastewater-based genomic surveillance (WWGS) emerged as an efficient viral surveillance tool that takes into account asymptomatic cases and can identify known and novel mutations and offers the opportunity to assign known virus lineages based on the detected mutations profiles. WWGS can also hint towards novel or cryptic lineages, but it is difficult to clearly iden…
▽ More
During the SARS-CoV-2 pandemic, wastewater-based genomic surveillance (WWGS) emerged as an efficient viral surveillance tool that takes into account asymptomatic cases and can identify known and novel mutations and offers the opportunity to assign known virus lineages based on the detected mutations profiles. WWGS can also hint towards novel or cryptic lineages, but it is difficult to clearly identify and define novel lineages from wastewater (WW) alone. While WWGS has significant advantages in monitoring SARS-CoV-2 viral spread, technical challenges remain, including poor sequencing coverage and quality due to viral RNA degradation. As a result, the viral RNAs in wastewater have low concentrations and are often fragmented, making sequencing difficult. WWGS analysis requires advanced computational tools that are yet to be developed and benchmarked. The existing bioinformatics tools used to analyze wastewater sequencing data are often based on previously developed methods for quantifying the expression of transcripts or viral diversity. Those methods were not developed for wastewater sequencing data specifically, and are not optimized to address unique challenges associated with wastewater. While specialized tools for analysis of wastewater sequencing data have also been developed recently, it remains to be seen how they will perform given the ongoing evolution of SARS-CoV-2 and the decline in testing and patient-based genomic surveillance. Here, we discuss opportunities and challenges associated with WWGS, including sample preparation, sequencing technology, and bioinformatics methods.
△ Less
Submitted 30 January, 2024; v1 submitted 23 September, 2023;
originally announced September 2023.
Dynamics of B-cell repertoires and emergence of cross-reactive responses in COVID-19 patients with different disease severity
Authors:
Zachary Montague,
Huibin Lv,
Jakub Otwinowski,
William S. DeWitt,
Giulio Isacchini,
Garrick K. Yip,
Wilson W. Ng,
Owen Tak-Yin Tsang,
Meng Yuan,
Hejun Liu,
Ian A. Wilson,
J. S. Malik Peiris,
Nicholas C. Wu,
Armita Nourmohammad,
Chris Ka Pun Mok
Abstract:
COVID-19 patients show varying severity of the disease ranging from asymptomatic to requiring intensive care. Although a number of SARS-CoV-2 specific monoclonal antibodies have been identified, we still lack an understanding of the overall landscape of B-cell receptor (BCR) repertoires in COVID-19 patients. Here, we used high-throughput sequencing of bulk and plasma B-cells collected over multipl…
▽ More
COVID-19 patients show varying severity of the disease ranging from asymptomatic to requiring intensive care. Although a number of SARS-CoV-2 specific monoclonal antibodies have been identified, we still lack an understanding of the overall landscape of B-cell receptor (BCR) repertoires in COVID-19 patients. Here, we used high-throughput sequencing of bulk and plasma B-cells collected over multiple time points during infection to characterize signatures of B-cell response to SARS-CoV-2 in 19 patients. Using principled statistical approaches, we determined differential features of BCRs associated with different disease severity. We identified 38 significantly expanded clonal lineages shared among patients as candidates for specific responses to SARS-CoV-2. Using single-cell sequencing, we verified reactivity of BCRs shared among individuals to SARS-CoV-2 epitopes. Moreover, we identified natural emergence of a BCR with cross-reactivity to SARS-CoV-1 and SARS-CoV-2 in a number of patients. Our results provide important insights for development of rational therapies and vaccines against COVID-19.
△ Less
Submitted 5 April, 2021; v1 submitted 13 July, 2020;
originally announced July 2020.
